Tenet Healthcare reported strong third quarter results with net income available to common shareholders of $472 million, or $4.89 per diluted share, and adjusted diluted earnings per share of $2.93. Consolidated Adjusted EBITDA increased 14.5% over the third quarter of 2023, driven by strong ambulatory care performance. The company raised its full year 2024 Adjusted EBITDA outlook by $50 million.
Net income available to common shareholders was $472 million, or $4.89 per diluted share, including an after-tax gain of $209 million from hospital divestitures.
Adjusted diluted earnings per share was $2.93.
Consolidated Adjusted EBITDA of $978 million increased 14.5% over the third quarter of 2023.
Ambulatory Care Adjusted EBITDA of $439 million increased 18.6% over the third quarter of 2023.
Tenet Healthcare's outlook for full year 2024 reflects the sale of hospitals in Coastal South Carolina, California, and Alabama. The company anticipates net operating revenues between $20.6 billion and $20.8 billion, and Adjusted EBITDA between $3.9 billion and $4.0 billion.
Visualization of income flow from segment revenue to net income